First Turn Management LLC's Q3 2024 13F: 13 new positions, 11 exits
Form 13F-HR for the quarter ended Sep 30, 2024 · filed Nov 7, 2024 · 38 reported positions · accession 0001085146-24-005432
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | SAREPTA THERAPEUTICS INC (SRPT) | 4.7% | — | −4.7 pts | −182K sh | −100% |
| New | NATERA INC (NTRA) | — | 3.1% | +3.1 pts | +156K sh | new |
| Exited | IMMUNOVANT INC (IMVT) | 3.0% | — | −3.0 pts | −695K sh | −100% |
| Exited | DEXCOM INC (DXCM) | 3.0% | — | −3.0 pts | −160K sh | −100% |
| New | ARCELLX INC (ACLX) | — | 2.8% | +2.8 pts | +214K sh | new |
| New | VERONA PHARMA PLC (VRNA) | — | 2.6% | +2.6 pts | +573K sh | new |
| New | HARROW INC (HROW) | — | 2.3% | +2.3 pts | +327K sh | new |
| Exited | ALPHATEC HLDGS INC (ATEC) | 2.3% | — | −2.3 pts | −1.36M sh | −100% |
| Exited | IDEAYA BIOSCIENCES INC (IDYA) | 2.3% | — | −2.3 pts | −398K sh | −100% |
| New | BICARA THERAPEUTICS INC (BCAX) | — | 2.3% | +2.3 pts | +562K sh | new |
| New | GERON CORP (GERN) | — | 2.2% | +2.2 pts | +3.12M sh | new |
| Reduced | ARGENX SE (ARGX) | 5.6% | 4.7% | −0.9 pts | −25,538 sh | −32% |
| New | ADMA BIOLOGICS INC (ADMA) | — | 2.1% | +2.1 pts | +665K sh | new |
| New | DAY ONE BIOPHARMACEUTICALS I (DAWN) | — | 2.1% | +2.1 pts | +948K sh | new |
| New | REPLIGEN CORP (RGEN) | — | 2.1% | +2.1 pts | +88,714 sh | new |
| Exited | REVOLUTION MEDICINES INC (RVMD) | 2.1% | — | −2.1 pts | −330K sh | −100% |
| Exited | APOGEE THERAPEUTICS INC (APGE) | 2.0% | — | −2.0 pts | −318K sh | −100% |
| New | GLAUKOS CORP (GKOS) | — | 2.0% | +2.0 pts | +96,097 sh | new |
| Exited | SPYRE THERAPEUTICS INC (SYRE) | 1.8% | — | −1.8 pts | −464K sh | −100% |
| Increased | NUVALENT INC (NUVL) | 3.1% | 5.8% | +2.7 pts | +107K sh | +42% |
| Increased | SYNDAX PHARMACEUTICALS INC (SNDX) | 2.1% | 3.6% | +1.5 pts | +547K sh | +85% |
| Exited | SILENCE THERAPEUTICS PLC (SLN) | 1.7% | — | −1.7 pts | −537K sh | −100% |
| New | BRIDGEBIO PHARMA INC (BBIO) | — | 1.6% | +1.6 pts | +400K sh | new |
| Exited | IMMUNOCORE HLDGS PLC (IMCR) | 1.6% | — | −1.6 pts | −291K sh | −100% |
| New | RELAY THERAPEUTICS INC (RLAY) | — | 1.4% | +1.4 pts | +1.23M sh | new |
| New | ARS PHARMACEUTICALS INC (SPRY) | — | 1.4% | +1.4 pts | +593K sh | new |
| Reduced | KALVISTA PHARMACEUTICALS INC (KALV) | 2.0% | 0.7% | −1.4 pts | −705K sh | −66% |
| Reduced | KRYSTAL BIOTECH INC (KRYS) | 3.3% | 2.0% | −1.3 pts | −41,280 sh | −38% |
| Reduced | AXSOME THERAPEUTICS INC (AXSM) | 4.4% | 3.6% | −0.8 pts | −81,952 sh | −24% |
| Reduced | VERTEX PHARMACEUTICALS INC (VRTX) | 3.9% | 2.6% | −1.3 pts | −15,470 sh | −31% |
| Reduced | INTRA-CELLULAR THERAPIES INC (ITCI) | 3.9% | 3.0% | −0.9 pts | −92,543 sh | −27% |
| Exited | DISC MEDICINE INC (IRON) | 1.0% | — | −1.0 pts | −139K sh | −100% |
| Reduced | INTUITIVE SURGICAL INC (ISRG) | 3.0% | 2.4% | −0.7 pts | −11,647 sh | −28% |
| Reduced | VAXCYTE INC (PCVX) | 3.2% | 3.8% | +0.6 pts | −48,296 sh | −19% |
| Reduced | ASCENDIS PHARMA A/S (ASND) | 4.1% | 3.6% | −0.6 pts | −35,988 sh | −19% |
| Increased | VERA THERAPEUTICS INC (VERA) | 1.3% | 2.3% | +1.0 pts | +114K sh | +53% |
| Reduced | TRANSMEDICS GROUP INC (TMDX) | 3.4% | 2.8% | −0.6 pts | −25,533 sh | −18% |
| Reduced | CYTOKINETICS INC (CYTK) | 2.6% | 1.9% | −0.7 pts | −70,171 sh | −24% |
| Increased | ENLIVEN THERAPEUTICS INC (ELVN) | 1.6% | 2.2% | +0.6 pts | +122K sh | +29% |
| Reduced | BIOHAVEN LTD (BHVN) | 2.1% | 2.5% | +0.4 pts | −50,203 sh | −14% |
| Increased | INSMED INC (INSM) | 3.5% | 4.1% | +0.6 pts | +33,091 sh | +10% |
| Reduced | MIRUM PHARMACEUTICALS INC (MIRM) | 3.9% | 4.0% | +0.1 pts | −55,787 sh | −8% |
| Increased | ROCKET PHARMACEUTICALS INC (RCKT) | 2.0% | 1.8% | −0.1 pts | +60,317 sh | +11% |
| Reduced | CRINETICS PHARMACEUTICALS IN (CRNX) | 2.7% | 2.9% | +0.2 pts | −15,926 sh | −4% |
| Reduced | MERUS N V (MRUS) | 3.1% | 2.4% | −0.7 pts | −13,892 sh | −4% |
| Reduced | ORIC PHARMACEUTICALS INC (ORIC) | 1.7% | 2.4% | +0.6 pts | −64,923 sh | −4% |
| Reduced | XENON PHARMACEUTICALS INC (XENE) | 2.2% | 2.0% | −0.1 pts | −14,658 sh | −4% |
| Reduced | ESTABLISHMENT LABS HLDGS INC (ESTA) | 2.7% | 2.4% | −0.3 pts | −12,977 sh | −4% |
| Reduced | BLUEPRINT MEDICINES CORP (BPMC) | 3.2% | 2.6% | −0.6 pts | −5,972 sh | −3% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 39.3% of the equity book
Changes in the top 10 this quarter: NUVL entered · PCVX entered · SNDX entered · NTRA entered · SRPT left · VRTX left · TMDX left · KRYS left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | NUVALENT INC (NUVL) | 3.1% | 5.8% | Entered the top 10 |
| 2 | ARGENX SE (ARGX) | 5.6% | 4.7% | |
| 3 | INSMED INC (INSM) | 3.5% | 4.1% | |
| 4 | MIRUM PHARMACEUTICALS INC (MIRM) | 3.9% | 4.0% | |
| 5 | VAXCYTE INC (PCVX) | 3.2% | 3.8% | Entered the top 10 |
| 6 | AXSOME THERAPEUTICS INC (AXSM) | 4.4% | 3.6% | |
| 7 | SYNDAX PHARMACEUTICALS INC (SNDX) | 2.1% | 3.6% | Entered the top 10 |
| 8 | ASCENDIS PHARMA A/S (ASND) | 4.1% | 3.6% | |
| 9 | NATERA INC (NTRA) | 0.0% | 3.1% | Entered the top 10 |
| 10 | INTRA-CELLULAR THERAPIES INC (ITCI) | 3.9% | 3.0% | |
| — | SAREPTA THERAPEUTICS INC (SRPT) | 4.7% | 0.0% | Left the top 10 |
| — | VERTEX PHARMACEUTICALS INC (VRTX) | 3.9% | 2.6% | Left the top 10 |
| — | TRANSMEDICS GROUP INC (TMDX) | 3.4% | 2.8% | Left the top 10 |
| — | KRYSTAL BIOTECH INC (KRYS) | 3.3% | 2.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).